00000nam 2200000za 4500 9.854395 CaOODSP 20221107155043 cr ||||||||||| 180327s2018 onc ob f000 0 eng d 9780660260105 CaOODSP eng n-cn--- H13-9/10-2018E-PDF Guidance document [electronic resource] : cancellation of a drug identification number (DIN) and notification of discontinuation of sales. Cancellation of a drug identification number (DIN) and notification of discontinuation of sales Cancellation of a DIN & notification of discontinuation of sales Ottawa : Health Canada, 2018. 18 p. Issued also in French under title: Ligne directrice : annulation d’une identification numérique d’une drogue (DIN) et avis de cessation de la vente d’une drogue. Cover title. "Date adopted: 2017/03/14. Revision date: 2018/06/13. Effective date: 2018/06/13." "Publication date: June 2018." Issued also in HTML format. Includes bibliographical references. "A Drug Identification Number (DIN) serves as an identifier of a drug and its associated characteristics. The assignment of a DIN indicates that a drug has undergone a successful Health Canada review process and is currently authorized for sale in Canada. The purpose of this guidance document is to provide assistance in interpreting sections C.01.014.6 and C.01.014.7 of the Regulations for the cancellation of a DIN and the notification to Health Canada of the discontinuation of the sale of a drug"--P. 7. Drugs Product elimination Handbooks Canada. Health Canada. Ligne directrice (CaOODSP)9.854397 PDF 295 KB https://publications.gc.ca/collections/collection_2018/sc-hc/H13-9-10-2018-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/regulatory-requirements-drug-identification-numbers/document.html 170513